SOLICITATION NOTICE
B -- Analysis of Serum Anti-Müllerian Hormone (AMH) Levels in Relationship to Mammographic Density and Measures of Lobular Involution in Premenopausal Participants in the BREAST Stamp and Komen Tissue Bank Studies by using a picoAMH ELISA array.
- Notice Date
- 4/26/2017
- Notice Type
- Presolicitation
- NAICS
- 541711
— Research and Development in Biotechnology
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 9609 Medical Center Drive, Room 1E128, Rockville, Maryland, 20852, United States
- ZIP Code
- 20852
- Solicitation Number
- N02CO72565-95
- Archive Date
- 5/26/2017
- Point of Contact
- Ricky J. Watson, Phone: 2402766594
- E-Mail Address
-
ricky.watson@nih.gov
(ricky.watson@nih.gov)
- Small Business Set-Aside
- N/A
- Description
- General Information Title: Analysis of Serum Anti-Müllerian Hormone (AMH) Levels in Relationship to Mammographic Density and Measures of Lobular Involution in Premenopausal Participants in the BREAST Stamp and Komen Tissue Bank Studies by using a picoAMH ELISA array. Document Type: Pres-Solicitation / Notice of Intent to Sole Source Solicitation Number: N02CO72565-95 Posted Date: 04/26/2017 Response Date: 05/11/2017 11:00 AM EST Classification Code: B NAICS Code: 541711 Contracting Office Address The Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 9609 Medical Center Drive, Room 1E140, Rockville, MD 20850, UNITED STATES Description The National Cancer Institute (NCI), plans to procure the following service, on a sole source basis, Analysis of Serum Anti-Müllerian Hormone (AMH) Levels in Relationship to Mammographic Density and Measures of Lobular Involution in Premenopausal Participants in the BREAST Stamp and Komen Tissue Bank Studies by using a picoAMH ELISA array from Ansh Labs, 445 Medical Center Blvd, Webster, TX 77598. The response close date of the notice for this requirement is in accordance with FAR 5.203(a)(1). This acquisition will be processed under FAR Part 12 - Acquisition for Commercial Items and will be made pursuant to the authority in FAR Part 13.106-1(b)(1); and is exempt from the requirements of FAR Part 6. The North American Industry Classification System code is 541711 and the business size standard is 1000 employees. It has been determined there are no opportunities to acquire green products or services for this procurement. Contractor Requirements The Contractor shall perform the picoAMH ELISA assay in a total of 1005 samples (n=953 study samples + 52 blinded quality control samples) from participants in the BREAST Stamp and Komen Tissue Bank Studies in order to assess the associations of AMH with measures of mammographic density and lobular involution. • The NCI will provide the Contractor with 120 μL of serum from each of 953 subjects and 52 masked quality control samples for assessment of AMH in a total of 1005 samples. The samples will be labeled with subject identification numbers only; patient identifiers will not be supplied. The NCI will ship the samples via Fed Ex frozen on dry ice. The NCI will provide a specimen manifest in the shipment. Upon receipt, the Contractor shall inventory the serum samples to confirm that the identification numbers, number of samples, and serum volumes match that in the specimen manifest. The Contractor shall notify the Contracting Officer's Technical Representative (COTR) of any discrepancies between the specimen manifest and specimens received within one week of shipment receipt. • After receiving the specimens, the Contractor shall store the samples in-house at -80°C until analyzed, with appropriate storage facilities that include sufficient emergency power supplies to prevent the accidental or unintended destruction or thawing of the specimens. • The Contractor shall perform ELISA assays for AMH on 1005 stored serum samples provided by NCI. The Contractor shall perform all analyses of specimens in the order provided by the NCI COTR and specified in the shipment manifest. • The Contractor shall perform all assays under conditions of careful quality control (QC), following the Contractor's usual laboratory quality control procedures and providing all internal quality control results for AMH to the NCI COTR. • The Contractor shall notify the NCI COTR within three days of the occurrence of any unusual problems that might affect or delay the completion of this project, such as failure of analytic or quality control procedures, breakdown of instrumentation and equipment, or changes in laboratory personnel. • The Contractor shall provide the assay results within an Excel spreadsheet within the period of the contract. • Upon completion of the assays, the Contractor shall return any unused frozen serum samples in their original tubes to an NCI biospecimen repository designated by the COTR. This notice is not a request for competitive quotation. However, if any interested party, especially small business believes it can meet the above requirement, it may submit a proposal or quote for the Government to consider. The response and any other information furnished must be in writing and must contain material in sufficient detail to allow NCI to determine if the party can perform the requirement. Responses must be received in the contracting office by 11:00 AM EST, on May 11, 2017. All responses and questions must be via email to Ricky Watson, Contract Specialist at ricky.watson@nih.gov. A determination by the Government not to compete this proposed requirement based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. In order to receive an award, contractors must be registered and have valid certification through SAM.GOV and have Representations and Certifications filled out. Reference: N02C072565-95 on all correspondence.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/RCB/N02CO72565-95/listing.html)
- Place of Performance
- Address: Bldg : EPS, Room: 5137, United States
- Record
- SN04487061-W 20170428/170427000116-b0a85ed587fb6d97cd842f003a813a51 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |